10x Genomics (TXG) Net Cash Flow Growth (1y) (2019 - 2026)
10x Genomics (TXG) Net Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | -43.71% |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 9,394.16% |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | -564.99% |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -50.15% |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | -76.26% |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 28,500.00% |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | -131.26% |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 248.05% |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | -175.74% |
| 10 | Omnicell | 1.81 Bn | 1.57 Bn | 140.36 Mn | 188.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.15% |
| Dec 31, 2025 | 176.57% |
| Sep 30, 2025 | 92.69% |
| Jun 30, 2025 | -15.62% |
| Mar 31, 2025 | 1,051.66% |
| Dec 31, 2024 | -221.03% |
| Sep 30, 2024 | 213.41% |
| Jun 30, 2024 | 370.42% |
| Mar 31, 2024 | -103.07% |
| Dec 31, 2023 | 407.79% |
| Sep 30, 2023 | 60.08% |
| Jun 30, 2023 | 76.68% |
| Mar 31, 2023 | 140.74% |
| Dec 31, 2022 | -11.91% |
| Sep 30, 2022 | -0.99% |
| Jun 30, 2022 | -903.58% |
| Mar 31, 2022 | -514.85% |
| Dec 31, 2021 | 91.08% |
| Sep 30, 2021 | -109.25% |
| Jun 30, 2021 | 116.82% |